Galactorrhea associated with juvenile systemic lupus erythematosus: A review of the role of prolactin

Pediatric Rheumatology

Volumn 7, Issue , 2009, Pages 17-

  Ronis, Tova ^a   Duffy, Ciarán M ^a   Duffy, Karen N W ^a  

^a MONTREAL CHILDREN S HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINUCLEAR ANTIBODY; CARDIOLIPIN ANTIBODY; CELL NUCLEUS ANTIGEN; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C4; LUPUS ANTICOAGULANT; PROLACTIN; RIBONUCLEOPROTEIN ANTIBODY; SM ANTIBODY;

ADOLESCENT; ANEMIA; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; CASE REPORT; COOMBS TEST; DISEASE ASSOCIATION; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; GALACTORRHEA; HUMAN; LEUKOPENIA; NEUTROPHIL COUNT; PARTIAL THROMBOPLASTIN TIME; PRIORITY JOURNAL; PROLACTIN BLOOD LEVEL; PROTEIN FUNCTION; RAYNAUD PHENOMENON; SYSTEMIC LUPUS ERYTHEMATOSUS;

EID: 70450257672     PISSN: None     EISSN: 15460096     Source Type: Journal    
DOI: 10.1186/1546-0096-7-17     Document Type: Article

References (18)

1. Sarzi-Puttini P, Panni B, Cazzola M, Muzzupappa S, Turiel M. Lamotrigine-induced lupus. Lupus 2000, 9:555-557. 10.1177/096120330000900715, 11035425.
2. Echaniz-Laguna A, Thiriaux A, Ruolt-Olivesi I, Marescaux C, Hirsch E. Lupus Anticoagulant Induced by the Combination of Valproate and Lamotrigine. Epilepsia 1999, 40(11):1661-1663. 10.1111/j.1528-1157.1999.tb02054.x, 10565597.
3. Lee T, von Scheven E, Sandborg C. Systemic lupus erythematosus and antiphospholipid syndrome in children and adolescents. Current Opinion in Rheumatology 2001, 13(5):415-21. 10.1097/00002281-200109000-00013, 11604598.
4. Erkan D, Harrison MJ, Levy R, Peterson M, Petri M, Sammaritano L, Unalp-Arida A, Vilela V, Yazici Y, Lockshin MD. Aspirin for primary thrombosis prevention in the antiphospholipid syndrome. Arthritis & Rheumatism 2007, 56(7):2382-2391.
5. Whitman-Elia GF, Windham NQ. Galactorrhea may be clue to serious problems: Patients deserve a thorough workup. Postgraduate Medicine 2000, 107(7):165-171.
6. Yazigi RA, Quintero CH, Salameh WA. Prolactin disorders. Fertility and Sterility 1997, 67(2):215-25.
7. Vera-Lastra O, Jara LJ, Espinoza LR. Prolactin and autoimmunity. Autoimmunity Reviews 2002, 1(6):360-364.
8. Dostál C, Marek J, Moszkorzová L, Lacinová Z, Musilová L, Zvárová J. Effects of stress of serum prolactin levels in patients with systemic lupus erythematosus. Annals of the New York Academy of Sciences 2002, 966:247-251.
9. Chikanza IC. Neuroendocrine immune features of pediatric inflammatory rheumatic diseases. Annals of the New York Academy of Sciences 1999, 876:71-80.
10. Jara LJ, Vera-Lastra O, Miranda JM, Alcala M, Alvarez-Nemegyei J. Prolactin in human systemic lupus erythematosus. Lupus 2001, 10(10):748-756.
11. Leaños-Miranda A, Pascoe-Lira D, Chávez-Rueda KA, Blanco-Favela F. Antiprolactin autoantibodies in systemic lupus erythematosus: Frequency and correlation with prolactinemia and disease activity. The Journal of Rheumatology 2001, 28(7):1546-1553.
12. Blanco-Favela F, Quintal M, Chavez-Rueda AK, Leaños-Miranda A, Berron-Peres R, Baca-Ruiz V, Lavalle-Montalvo C. Anti-prolactin antibodies in paediatric systemic lupus erythematosus patients. Lupus 2001, 10(11):803-808.
13. Méndez I, Alcocer-Varela J, Para A, Lava-Zavala A, de la Cruz DA, Alarcón-Segovia D, Larrea F. Neuroendocrine dopaminergic regulation of prolactin release in systemic lupus erythematosus: A possible role of lymphocyte-derived prolactin. Lupus 2004, 13(1):45-53.
14. Vera-Lastra O, Mendez C, Jara LJ, Cisneros M, Medina G, Ariza R, Espinoza LR. Correlation of prolactin serum concentrations with clinical activity and remission in patients with systemic lupus erythematosus: Effect of conventional treatment. The Journal of Rheumatology 2003, 30(10):2140-2146.
15. Hattori N, Inagaki C. Anti-prolactin (PRL) autoantibodies cause asymptomatic hyperprolactinemia: bioassay and clearance studies of PRL-Immunoglobulin G Complex. Journal of Clinical Endocrinology and Metabolism 1997, 82:3107-3110.
16. El-Graf A, Salah S, Shaarawy M, Zaki S, Anwer S. Prolactin hormone in juvenile systemic lupus erythematosus: A possible relationship to disease activity and CNS manifestation. The Journal of Rheumatology 1996, 23:374-377.
17. Canadian Pharmacists Association. CPS Compendium of Pharmaceuticals and Specialties, The Canadian Drug Reference for Health Professionals 2009,
18. IMMULITE Prolactin product monograph. , http://diagnostics.siemens.com